K221765

Substantially Equivalent

ONLINE DAT Benzodiazepines II

Applicant: Roche Diagnostics
Product code: JXM
Advisory panel: Clinical Toxicology
Date received: 2022-06-17
Decision date: 2022-12-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.